Innovative Implant Uses Oxygenation to Treat Type 1 Diabetes
A new implant system developed at Cornell University offers a promising approach to treating type 1 diabetes by oxygenating insulin-producing cells, potentially reducing dependence on immunosuppressive drugs and enabling better disease management.
Researchers at Cornell University have developed a groundbreaking implant system designed to treat type 1 diabetes by enhancing oxygen supply to insulin-producing cells. This novel device delivers oxygen directly to densely packed pancreatic cells, allowing them to function effectively without needing immunosuppressive drugs. The system consists of a cylindrical capsule housing transplanted insulin-secreting cells and a compact electrochemical oxygen generator the size of a dime, which can be removed as needed. A nanofibrous membrane protects the cells from immune attacks, while a permeable membrane ensures the transfer of oxygen and nutrients.
The technology builds upon previous implantable devices developed in the lab of Professor Minglin Ma, who has previously achieved success controlling blood sugar in diabetic mice but faced limitations due to oxygen deprivation leading to cell death. By introducing the oxygen generator, the new system maintains an adequate oxygen supply, significantly prolonging the survival and functionality of transplanted cells.
The device has been successfully tested in rat models, demonstrating its potential to support high-density cell transplantation and immune protection. Future steps include testing in pig models and exploring applications for other chronic diseases requiring local delivery of therapeutic molecules.
This approach could revolutionize treatment options for the approximately 2 million people with type 1 diabetes in the U.S., enabling more effective and potentially curative therapies without the risks associated with immune suppression. The implant's ability to provide tighter sugar control could allow patients to manage their condition naturally, with fewer daily interventions.
The system's innovative design emphasizes immune protection, efficient oxygenation, and compatibility with long-term use, paving the way for advanced cell therapies. The research team is also exploring broader applications, including delivering other therapeutic proteins and addressing autoimmune and inflammatory diseases.
Source: https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
RSV Vaccination Reduces Cardiorespiratory Hospitalizations in Adults Over 60
A recent study shows that RSV vaccination in adults over 60 can significantly lower the risk of severe cardiorespiratory hospitalizations, enhancing health outcomes during the winter season.
Innovative Focused Intervention Reduces Bias in Family Planning Clinics
A pioneering study finds targeted interventions in family planning clinics effectively reduce provider bias, enhancing contraceptive access for young women worldwide. This approach promotes respectful, inclusive reproductive health services across diverse settings.
Innovative WiFi Technology Enables Heart Rate Monitoring Without Wearables
A new study from UC Santa Cruz introduces Pulse-Fi, a system that uses standard Wi-Fi signals and machine learning to monitor heart rate accurately without wearable devices, opening new possibilities for accessible health tracking.
Innovative Gene Therapy Restores Hearing in Patients with Congenital Deafness
A novel gene therapy has successfully restored hearing in patients with genetic deafness, showing rapid and safe results in both children and adults, paving the way for personalized auditory treatments.